Spatial-hindrance-based pro-Adalimumab prevents anti- idiotypic antibody interference in pharmacokinetic and therapeutic efficacy
Contact Us
+886 7 311 1577
｜Taipei office｜
17F, No. 3, Park St., Nangang Dist., Taipei City 115, Taiwan
｜R&D Center｜
12F, 1st Teaching Building, 100, Shih-Chuan 1st Rd., Sanmin Dist., Kaohsiung 807, Taiwan
